Cargando…
Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy
AIMS: Atrial fibrillation (AF) is a risk for patients receiving thyroid hormone replacement therapy. No published work has focused on pharmacogenetics relevant to thyroid dysfunction and AF risk. We aimed to assess the effect of L-thyroxine on AF risk stratified by a variation in a candidate gene. M...
Autores principales: | Soto-Pedre, Enrique, Siddiqui, Moneeza K., Maroteau, Cyrielle, Dawed, Adem Y., Doney, Alex S., Palmer, Colin N. A., Pearson, Ewan R., Leese, Graham P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260687/ https://www.ncbi.nlm.nih.gov/pubmed/34249083 http://dx.doi.org/10.3389/fgene.2021.652878 |
Ejemplares similares
-
A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
por: Bigossi, Margherita, et al.
Publicado: (2023) -
Common Statin Intolerance Variants in ABCB1 and LILRB5 Show Synergistic Effects on Statin Response: An Observational Study Using Electronic Health Records
por: Melhem, Alaa’ Lutfi, et al.
Publicado: (2021) -
Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT
por: Soto-Pedre, Enrique, et al.
Publicado: (2022) -
Weight variability and cardiovascular outcomes: a systematic review and meta-analysis
por: Massey, Robert J., et al.
Publicado: (2023) -
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
por: Siddiqui, Moneeza K., et al.
Publicado: (2021)